ClinicalTrials.gg
CompletedNCT04385446Updated May 13, 2020

Comparative Study of Muc5ac and Muc2 Mucins in Tear Film Concentration in Surgical Treated Pterygia Patients

An interventional study of Amniotic membrane transplantation in Pterygium of Both Eyes, sponsored by Instituto de Oftalmología Fundación Conde de Valenciana. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-05-13.

Sponsored by Instituto de Oftalmología Fundación Conde de Valenciana · Not applicable, Interventional, and Screening

From the registry’s dates

  • Registered 4 years 2 months after the study started (first participant enrolled Feb 2016, registered Apr 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

To identify and compare the differences in the concentration of the Muc2 and Muc5AC mucins in tear film in patients who underwent pterygium surgery using amniotic membrane transplantation and conjunctival autograft surgery.

Read the detailed description

Patients with nasal, primary pterygium bigger than 1 mm of corneal invasion with residence in Mexico City and older than 18 years were included. Under informed consent, patients were divided into two groups in a random fashion. Pterygium surgery was carried out with conventional technique performing amniotic membrane transplantation for group A, and conjunctival autograft for group B. Muc2 and muc5ac mucin concentration was measure min tear film by ELISA; samples were taken before surgery, at first, third and sixth month postoperatively. BUT was also measured on the same dates. Descriptive statistics and the U-Mann Whitney test for independent groups, considering a p≤0.05 as significant were used for analysis.

02

Conditions studied

  • Pterygium of Both Eyes

Browse trials for

Keywords

  • pterygium, amniotic membrane, conjunctival autograft, ocular mucin
03

In context

Pterygium

109 studies on the registry are indexed under Pterygium; 9 are open to participants now.

This study's enrollment of 44 is below the median of 60 across 93 interventional studies indexed under Pterygium.

Browse Pterygium studies →

Lead sponsor

Instituto de Oftalmología Fundación Conde de Valenciana is the lead sponsor of 45 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with nasal, primary pterygium bigger than 1 mm.

Exclusion criteria

Exclusion Criteria:

  • Diabetes mellitus, single eye.
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
44 participants (actual)

Study arms

  • Active comparator
    Amniotic membrane transplantation

    Amniotic membrane transplantation was used as covering material in the area where the pterygium tissue was removed during the surgery.

    Procedure: Amniotic membrane transplantation

  • No intervention
    conjnctival autograft.

    Conjunctival autograft was used as a covering material in the area where the pterygium tissue was removed during the surgery.

Interventions

  • ProcedureAmniotic membrane transplantation

    Amniotic membrane transplantation was used as covering material during pterygium surgery.

06

What researchers measure

Primary outcomes

  1. Ocular Tear film Mucin MUC5ac concentration.

    Using a capillary tube, tear film was collected en every patient. Then Concentration of mucin MUC5ac were measured by Elisa technique using a quantitative scale.

    Time frame: The patients will be assed during six months

  2. Ocular tear film Mucin MUC2 concentration.

    Using a capillary tube, tear film was collected en every patient. Then Concentration of mucin MUC2 were measured by Elisa technique using a quantitative scale.

    Time frame: The patients will be assed during six months

  3. Tear film breakup time.

    Tear film breakup time is the time between a complete blink and the appearance of the first random corneal dry spot and indicates relative tear film stability.

    Time frame: The patients will be assed during six months

Secondary outcomes

  1. Pterygium recurrence.

    Pterygium recurrence was defined as any fibrovascular proliferation from the original pterygium site from it was surgically removed.

    Time frame: The patients will be assed during six months

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2016 to primary completion in Feb 2017, 12 months.

Of 18 interventional studies with no phase under Pterygium, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 28. This study's 12 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 29, 2020
First posted
May 13, 2020
StartActual
Feb 2, 2016
Primary completionActual
Feb 7, 2017
CompletionActual
Sep 5, 2018
Last update
May 13, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04385446
Lead sponsor
Instituto de Oftalmología Fundación Conde de Valenciana
Responsible party
Sponsor
First posted
May 13, 2020
Start date
Feb 2, 2016
Primary completion
Feb 7, 2017
Completion
Sep 5, 2018
Last update
May 13, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion